Concepedia

G. Borthakur

GB

Statistics

Publications

16

Citations

1.5K

H-Index

14

Active since

2007

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Scott & White Memorial Hospital

G. Borthakur is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and oncology.

Publications per year

2007–2020

16

Publications

16

Pleural Effusion in Patients With Chronic Myelogenous Leukemia Treated With Dasatinib After Imatinib Failure

Alfonso Quintás‐Cardama, Hagop M. Kantarjian, Susan O’Brien et al. · Journal of Clinical Oncology · 2007 · 392 citations

, , +8

Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls

Srđan Verstovšek, Hagop M. Kantarjian, Zeev Estrov et al. · Blood · 2012 · 216 citations · Full text

, , +7

Phase I study of sorafenib in patients with refractory or relapsed acute leukemias

G. Borthakur, Hagop M. Kantarjian, Farhad Ravandi et al. · Haematologica · 2010 · 204 citations · Full text

, , +17

Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes

Guillermo Montalban‐Bravo, Rashmi Kanagal‐Shamanna, Christopher B. Benton et al. · Blood Advances · 2020 · 132 citations · Full text

, , +17

NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy

Guillermo Montalban‐Bravo, Rashmi Kanagal‐Shamanna, Koji Sasaki et al. · Blood Advances · 2019 · 111 citations · Full text

, , +17

1–5 of 16